Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies Academic Article uri icon

Overview

MeSH Major

  • Fallopian Tube Neoplasms
  • Infusions, Parenteral
  • Intestinal Obstruction
  • Ovarian Neoplasms
  • Peritoneal Neoplasms

abstract

  • Intestinal obstructions developed in a third of patients who received IP therapy as part of their treatment for advanced ovarian, tubal, or peritoneal cancer. However, the majority of the obstructions are related to progression of malignant intra-abdominal disease. Only 4% of the patients develop intestinal obstruction due to intestinal adhesions after IP treatment.

publication date

  • May 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2009.01.016

PubMed ID

  • 19254808

Additional Document Info

start page

  • 228

end page

  • 32

volume

  • 113

number

  • 2